Article Versions Notes

Guo C-L, Wang L-J, Zhao Y, Liu H, Li X-Q, Jiang B, Luo J, Guo S-J, Wu N, Shi D-Y. A Novel Bromophenol Derivative BOS-102 Induces Cell Cycle Arrest and Apoptosis in Human A549 Lung Cancer Cells via ROS-Mediated PI3K/Akt and the MAPK Signaling Pathway. Marine Drugs. 2018; 16(2):43. https://doi.org/10.3390/md16020043

Guo, Chuan-Long, Li-Jun Wang, Yue Zhao, Hua Liu, Xiang-Qian Li, Bo Jiang, Jiao Luo, Shu-Ju Guo, Ning Wu, and Da-Yong Shi. 2018. "A Novel Bromophenol Derivative BOS-102 Induces Cell Cycle Arrest and Apoptosis in Human A549 Lung Cancer Cells via ROS-Mediated PI3K/Akt and the MAPK Signaling Pathway" Marine Drugs 16, no. 2: 43. https://doi.org/10.3390/md16020043

Guo, C.-L., Wang, L.-J., Zhao, Y., Liu, H., Li, X.-Q., Jiang, B., Luo, J., Guo, S.-J., Wu, N., & Shi, D.-Y. (2018). A Novel Bromophenol Derivative BOS-102 Induces Cell Cycle Arrest and Apoptosis in Human A549 Lung Cancer Cells via ROS-Mediated PI3K/Akt and the MAPK Signaling Pathway. Marine Drugs, 16(2), 43. https://doi.org/10.3390/md16020043